Back to
Axiom Investors LLC
PTGX
7 quarters
Position history for
Axiom Investors LLC's holdings in Protagonist Therapeutics, Inc.
Yes. Axiom Investors holds 83,951 shares of PTGX, worth $11.8M, as of its Q3 2026 13F filing. It increased the position by 2,268 shares (+2.8%) from Q2 2026. Axiom Investors has held PTGX since Q1 2025, across 7 quarterly 13F filings. PTGX is 0.1% of Axiom Investors' reported 13F portfolio.
Current Value
$11.8M
Current Shares
83,951
Total Value Change
+$9.9M
Total Shares Change
+43,982
Quarter-by-Quarter History